Erythropoietin (EPO), a hematopoietic cytokine, demonstrates significant neuroprotective potential in AD through maintaining neuronal survival, regulating neurogenesis, and activating multiple cellular signal modulations that inhibit apoptotic proteins and block TNFα-induced caspase activation [145]. Here, EPO is linked to Alzheimer disease.